📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals. (2021)

First Author: Manisty C

Attributed to: 'REBRACOVID' - multicentre cohort study of the natural history and immunology of COVID-19 in Brazil funded by GCRF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(21)00501-8

PubMed Identifier: 33640038

Publication URI: http://europepmc.org/abstract/MED/33640038

Type: Journal Article/Review

Volume: 397

Parent Publication: Lancet (London, England)

Issue: 10279

ISSN: 0140-6736